Introduction
Microneedles (MN) are minimally invasive transdermal drug delivery platforms [1, 2] . This technology creates micropores in the stratum corneum, which enables the transdermal delivery of a broad range of therapeutics that cannot permeate intact skin [3] . Compared to MN made of metal, ceramics and silicon, polymeric MN are gaining attention due to their nontoxicity, biodegradability, biocompatibility, and easy fabrication [4] .
In the design and development of the MN, it is often necessary to visualize and characterize the MN penetration, dissolvation or swelling, and biodegradation as well as the drug release profile and distribution in skin. Currently, researchers rely mainly on ex vivo techniques such as biopsy and histological staining. However, these methods are cumbersome and timeconsuming, requiring the excision and processing of tissue specimens. In addition, the results derived with such destructive methods are often inaccurate as skin tissue is elastic and usually do not retain the microstructure generated during MN intrusion. Therefore, imaging technologies that provide real-time, non-invasive, in situ or in vivo images of the MN penetration and swelling in skin are highly desired.
Optical coherence tomography (OCT) is a commonly utilized optical imaging tool in MN-based studies, and has been illustrated in real time studies to visualize and monitor MN dissolution and swelling in skin [5] [6] [7] . However, this technique is limited by its shallow imaging depth and poor contrast between the MN and the skin tissue [8] . In a particular MN study by Tsai et al. OCT was implemented to study MN penetration and dissolution but to observe the drug release profile of an encapsulated drug fluorescence microscopy was used [9] . In similar OCT studies, post-processing of images using false colors was performed to evaluate MN penetration and dissolution [10] . Thus, alternative imaging tools which can provide real time characterization of drug release profiles induced by MN is critical in supplementing the growing potential of MN based drug delivery systems.
Photoacoustic Microscopy (PAM) is a fast-growing hybrid in vivo imaging modality combining optical contrast with ultrasound resolution [11] [12] [13] [14] [15] [16] [17] . It provides penetration beyond optical mean free path (~1 mm in skin) with high resolution (a lateral resolution within tens of microns and an axial resolution within hundreds of microns) and has been successfully applied to in vivo structural, functional, molecular, and cell imaging [16, [18] [19] [20] [21] . In this process, PAM utilizes a short laser pulse to irradiate the tissues. There will be a temperature rise due to absorption of light by the tissue chromophores (such as melanin, red blood cells, water etc.), which in turn produces pressure (acoustic waves) waves. A wideband ultrasonic transducer receives the acoustic signal outside the tissue boundary for reconstructing the optical absorption map inside the tissue. PAM overcomes the limitations of other existing optical modalities, combining optical contrast with ultrasound resolution. In PAM, the resolution is not limited by optical diffusion due to multiple photon scattering whereas contrast is related to the optical properties of the tissue. Unlike optical coherence tomography, diffuse optical tomography and fluorescence tomography, PAM does not rely on ballistic or backscattered light. Any light, including both singly and multiply scattered photons, contributes to the imaging signal. As a result, the imaging depth in PAM is relatively large. PAM has the ability to penetrate deeper and sustain high spatial resolution. Compared with ultrasonic imaging, PAM has rich intrinsic and extrinsic optical contrasts and is free of speckle artifacts [22] .
PAM can be classified into acoustic resolution photoacoustic microscopy (AR-PAM) and optical resolution photoacoustic microscopy (OR-PAM). In AR-PAM deep tissue imaging can be achieved with weak optical and tight acoustic focusing. Resolving single capillaries acoustically will need ultrasonic transducers greater than 400 MHz central frequency; but at this frequency the penetration depth will be less than 100 µm. Therefore, tight optical focusing has been used in OR-PAM to achieve higher spatial resolution. OR-PAM can resolve single capillaries or even a single cell [23] , and a lateral resolution up to 0.5 µm has been achieved [17, 24, 25] . Although the penetration depth of OR-PAM is limited due to light focusing, it can still image up to a maximum of 1.2 mm inside the biological tissue [17] .
We hypothesize that OR-PAM can be used to observe the penetration of MN through skin and simultaneously observe the transdermal delivery of therapeutics. As a proof-of-concept, we first study the skin penetration of PMMA MN using OR-PAM. Then using gold nanoparticles (AuNPs) as a model drug, we examine the penetration, diffusion, and distribution of AuNPs in mice skin (in vivo) after the MN-assisted delivery.
Materials and methods
All chemical reagents unless specifically mentioned were obtained from Sigma-Aldrich (Singapore) and used without any modification.
Fabrication and characterization of AuNPs coated MN arrays
The MN were designed by Micropoint Technologies Pte Ltd (Singapore) using poly(methyl methacrylate) (PMMA) polymer in a 10×10 array with height of 600μm and base width of 300µm. PMMA polymer was chosen for its safety and high mechanical toughness to withstand MN compression when inserted into skin. Briefly, the fabrication methodology involved an injection molding process with an injection melt temperature of 293°C, mold temperature between 60-120°C, injection velocity of 150 mm/s and hold pressure of 48 MPa.
The PMMA MN were coated with 100 nm AuNPs. Briefly, the surface of the PMMA MN was thoroughly washed with acetone and blown dry with nitrogen gas. The MN surface was then plasma treated using Harrick Plasma Cleaner PDC 32G. The MN were dipped into 0.1 ml of concentrated AuNPs solution for several times ensuring that the solution covered the surface of the MN and was dried in the oven at 80° C overnight.
To evaluate the MN skin insertion ability, MN patches were inserted into treated fresh porcine skin using an applicator and removed after 1 minute retention. Later, the skin tissue was fixed and stained using Hematoxylin and Eosin (H&E) for histological analysis.
Optical resolution photoacoustic microscopy system
The OR-PAM system [ Fig. 1 ] employs a nanosecond tunable laser system; consist of a diodepumped solid-state Nd-YAG laser and a dye laser. The laser system can be tunable between 559 nm-576 nm. The laser beam was reshaped by an iris and then spatially filtered by a combination of condenser lens, CL (LA4327, Thorlabs) and a 50 μm pinhole, PH (P50S, Thorlabs). The attenuated beam through a variable neutral density filter, NDF (NDC-50C-4M), was launched on to a single-mode fiber, SMF (P1-460B-FC-1, Thorlabs) using a fiber coupler, FC (F-91-C1, Newport). The beam out from the SMF was collimated by an Achromatic lens, L1 (32-317, Edmund Optics), reflected by a stationary elliptical mirror, M and filled the entire back aperture of another identical Achromatic lens, L2. The focusing beam will be passed through a optoacoustic beam combiner which consist of a right angled prism, RA (PS615, Thorlabs) and a rhomboid prism, RP (47-214, Edmund optics) with a layer of silicon oil, SO (DMPS1M, Sigma Aldrich) in between. The silicon oil layer acts as acoustic reflective and optical transparent film. An acoustic lens, AL (LC4573, Thorlabs) was attached at the bottom of the rhomboid prism provided acoustic focal diameter ~46 μm. The ultrasonic transducer (UST), 50 MHz center frequency was placed on top of the rhomboid. The optical and acoustic foci were aligned confocally to maximize the detection sensitivity. The laser repetition rate for the OR-PAM was set to 5 kHz and the laser energy at focus can be varied up to 200 nJ per pulse. The laser wavelength was set at 570 nm. The OR-PAM scanner head was attached to a 3-axis motorized stage connected to the computer. For photoacoustic imaging the bottom of the OR-PAM scanner head was submerged in a water-filled tank. For optical and acoustic transmission an imaging window (7 cm x 7 cm) was opened in the bottom of the tank and sealed with a polyethylene membrane. The PA signal acquired by the UST was amplified by two 24 dB amplifiers (ZFL-500LN, Mini Circuits), and was recorded in a desktop computer using a data acquisition card, DAQ. The scanning and data acquisition was controlled using Labview software. The synchronization of the data acquisition and the stage motion was controlled through the signal from a photodiode, PD. Two-dimensional continuous raster scanning of the imaging head was used during image acquisition. This OR-PAM system has a spatial resolution of ~4.2 micron, axial resolution of ~33 micron, and an imaging depth up to ~1.4 mm as characterized previously [26, 27] .
Laser safety
For in vivo imaging, according to American National Standards Institute (ANSI) laser safety standards [28] , the maximum pulse energy by a single laser pulse (MPESP) on the skin surface shouldn't exceed MPE SP = 2. C A × 10 −2 J cm 2 ⁄ , where CA the wavelength correction factor, unity for visible wavelength range (400-700 nm). If a point on skin is exposed to more than 10 sec the irradiance shouldn't exceed 200 mW/cm 2 . In the case of raster scanning a point on the skin won't be exposed for 10 sec, hence the maximum permissible exposure (MPEAVG) is limited by 1.1CA t 0.25 in mJ/ cm 2 where t denotes the exposure duration in seconds. For OR-PAM we believe due to optical aberrations at the prism surface and acoustic lens objective NA might have reduced the from 0.11 to 0.075. Assuming the optical focus is 150 micron below the skin surface for in vivo imaging, the surface spot size was 22.5 µm in diameter and the calculated optical fluence for a single laser pulse was 20.4 mJ/cm 2 (90 nJ/pulse) close to the safety limit. Having a minimum pixel separation of 2 µm, an average of 11 (N) adjacent laser pulses overlaps on the skin surface. At 5 kHz LRR the exposure time is 2.4 ms. So the MPETRAIN was 238 mJ/cm 2 .The MPESP for the pulse train was (MPEAVG) = MPETRAIN / N = 238 /11 = 21.6 mJ/cm 2 close to the maximum permissible limit.
Imaging methodology
The ear of a female mice of body weight 25 g and age 4 weeks, procured from InVivos Pte. Ltd. Singapore, were used in the imaging experiments. Animal experiments were performed according to the approved guidelines and regulations by the institutional Animal Care and Use committee of Nanyang Technological University, Singapore (Animal Protocol Number ARF-SBS/NIE-A0263). The animals were anesthetized using a cocktail of Ketamine (120 mg/kg) and Xylazine (16 mg/kg) injected intraperitoneally (dosage of 0.1 ml/10 gm). After removing hair from the ear the mouse was positioned on a microscopic glass slide before the MN coated with AuNPs was pressed into a mouse ear using an applicator. MN was inserted into mouse ear for 60 seconds and removed before OR-PAM imaging was performed. Mouse ear was used as a suitable model to mimic the human epidermis thickness. In addition, the planar surface of the mouse ear tissue enables uniform pressure to be applied during MN insertion to ensure fair distribution of AuNPs in the treated region for effective monitoring of AuNPs delivery. The animal was further anesthetized with vaporized isoflurane system (1 L/min oxygen and 0.75% isoflurane) during the imaging period. The imaging region was made in contact with the polyethylene membrane using ultrasound gel. In order to characterize the penetration depth as well as the rate of diffusion of AuNPs at each depth, a smaller region of interest (1.5 mm × 0.75 mm) was scanned at different time intervals after MN insertion with a step size of 2 µm along Xaxis and 4 µm long Y-axis. A 2 mm × 1.25 mm untreated area of the mouse ear was imaged as a control image with a step size of 2 µm along X-axis and 5 µm along Y-axis.
Results and discussion

AuNPs coated MN array
The fabricated MN array has a dimension of 1 cm by 1 cm with solid MN tips of height 600 µm and base width of 350µm [ Figs. 2(a) and 2(b) ]. The PMMA MN could easily penetrate the fresh porcine skin tissue to a depth of 400µm as observed in the H&E staining, in which MN tip reached the dermis layer [ Fig. 2(c)] . The difference between the needle length and the actual penetration depth (displacement) should be due to the elasticity of skin [29] . The observed penetration depth is enough for effective intradermal drug delivery in humans. In this study, AuNPs are taken as the model drugs for MN mediated transdermal delivery. AuNPs are capable of enhancing singlet oxygen generation and have shown to improve the efficacy of conventional photodynamic therapy [30, 31] . Hence, AuNPs can be used as potential therapeutic agents to destroy tumor cells [32, 33] . They were coated on PMMA MN via facile dip-coating. The coated MN kept the same morphology as before [ Fig. 3(a) ]. At a greater magnification, clusters of AuNPs can be observed on the pyramidal sides of the MN tips [ Fig.  3(b) ]. Taking together, the dip-coating successfully coated MN with AuNPs without influencing the structural integrity of the MN. Fig. 4(a) ] before the MN treatment shows the blood vessel structures present inside the mouse ear. Following the insertion of AuNPs coated MN, certain areas of the microvasculature [white dotted box, Fig. 4(b) ], were observed to have nanoparticle deposition in a patterned way similar to the arrangement of the MN tips in the designed MN array. As AuNPs have a strong optical absorption (resulting in strong photoacoustic signal), monitoring the delivery of these particles in the skin after the detachment from the MN is easily achieved. This concludes the successful MN penetration and delivery of the AuNPs using the MN. In addition, it is also notable that no visible damage to the blood vessels structure was observed following the MN intervention. In addition, the rate of diffusion was significant in the first 90 minutes following MN insertion and no significant decrease in the PA amplitude was observed thereafter. These results can be well understood with Fick's First Law of Diffusion; which states that particles diffuse with a flux proportional to the concentration gradient. As time progressed, the AuNPs diffused laterally in a steady state and hence at each of the depth, we observe a similar trend in the PA signal. The PA amplitude signal measured at the surface of the tissue is comparable to the signal attained at a depth of 180 µm. This can be explained by the limitation of the sampled tissue as the mice ear has a thickness of 150-170 µm.
Photoacoustic imaging of the skin penetration of MN
The fast diffusion process of AuNPs (approximately ~20 minutes) inside the tissue indicates that it can be an ideal candidate for photodynamic therapy [34] . On the contrary, therapeutics delivered intravenously can potentially elicit toxicity to normal cells and cause severe side effects. As such, MN can be explored as an improved target specific therapeutic delivery tool. To use MN in a photosensitizing drug delivery platform, it is important to visualize and characterize the MN properties including penetration depth, dissolution in skin as well as the drug release profiles. Photoacoustic imaging has already shown potential towards clinical translations [35] and the feasibility for making portable handheld devices makes PAM a promising imaging tool for clinical translations [36] [37] [38] . Photoacoustic microscopy can help in in vivo monitoring of these parameters and thus may play an important role in the development of drug coated MN therapy. Although most OR-PAM system use visible wavelength for imaging blood vasculature, near infrared (NIR) wavelength window can provide much deeper imaging (up to 3.2 mm), due to the reduced scattering and absorption by the tissue [39] . Therefore, NIR OR-PAM systems can also be used for monitoring in vivo nanoparticle delivery using MN. We have selected AuNPs having absorption in the 570 nm wavelength as the model drug in this study. The technology can be used for different drug delivery monitoring by choosing appropriate drug having absorbance in the specific wavelength of the laser used. Numerous drug carriers have capability of providing strong PA signals, including carbon nanotubes, gold nanoparticles, porphysomes etc. By loading conventional drugs into these nanocarriers, the nanocarrier can be non-invasively imaged and assessed. Another way is to co-load drugs of interest with small molecule NIR dyes into a common carriers [40, 41] . A detailed study by using NIR laser and gold nanorods (or other nanocarriers) as the model drug using different MN needs to be carried out to demonstrate better visualization of maximum penetration depth and drug delivery.
Conclusion
For the first time, we reported the use of OR-PAM to study the MN skin penetration and delivery of AuNPs in vivo using mice model. We can see that MN were able to efficiently penetrate skin tissue and deliver the AuNPs up to a depth of ~150 µm. The diffusion pattern of delivered AuNPs in the skin tissue was observed and found to take ~90 minutes post the MN insertion. This work reveals the potential use of photoacoustic microscopy in the in vivo monitoring of transdermal drug delivery using MN platforms.
